PRP guidelines · International

Short-Term Outcomes of Percutaneous Trephination with a Platelet Rich Plasma Intrameniscal Injection for the Repair of Degenerative Meniscal Lesions. A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study

Rafal Kaminski, Marta Maksymowicz-Wleklik, Krzysztof Kulinski, Katarzyna Kozar- Kaminska, Agnieszka Dabrowska-Thing, Stanislaw Pomianowski

International Journal of Molecular Sciences · 2019

In brief

This double-blind, placebo-controlled randomised trial examined chronic degenerative meniscal tears treated with needle trephination, with or without platelet-rich plasma (PRP) injected into the meniscus. The authors report fewer healing failures and fewer later arthroscopies when PRP was added, along with more patients reaching meaningful symptom improvement.

Read the original paper (opens in a new tab)

Citation, as listed in the PRP guidelines

Short-Term Outcomes of Percutaneous Trephination with a Platelet Rich Plasma Intrameniscal Injection for the Repair of Degenerative Meniscal Lesions. A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Authors: Rafal Kaminski, Marta Maksymowicz-Wleklik, Krzysztof Kulinski, Katarzyna Kozar- Kaminska, Agnieszka Dabrowska-Thing, Stanislaw Pomianowski Link: https://www.ncbi.nlm.nih.gov/pubmed/30781461 Year of Publication: 2019

A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.

More from the PRP guidelines

Ready to rewrite your health story?

Request a callback from our team.